期刊文献+

uPA、uPAR及PAI-1在结肠癌侵袭和转移中的作用及其相关性 被引量:5

Relation of uPA,uPAR,PAI-1 to invasion and metastasis of colon cancer and their relationship
下载PDF
导出
摘要 目的:对尿激酶型纤溶酶原激活物(uPA)及其受体uPAR和血浆纤溶醇原激活物抑制因子PAI-1在结肠癌侵袭和转移中的作用及其相关性进行研究。方法:选择临床病理资料完整的结肠癌蜡块标本156例,正常结肠黏膜标本50例作对照。采用SP免疫组化方法检测uPA、uPAR及PAI-1在其中的表达。结果:uPA及uPAR在结肠癌组织中高表达,并随病理分级的降低、淋巴转移的产生、临床分期的提高而明显增高(P均<0.05)。PAI-1在结肠癌组织中高表达,并随分级的降低、淋巴结转移的产生、临床分期的提高而明显增高(P均<0.05)。结肠癌中uPA、uPAR及PAI-1的表达呈正相关(P<0.01)。结论:uPA、uPAR及PAI-1对结肠癌的侵袭和转移起重要的促进作用并在结肠癌的侵袭和转移相互促进,相互协调,关系密切。uPA、uPAR及PAI-1各自都可以成为结肠癌诊断和预后估计的指标,并且有可能成为结肠癌基因治疗的新靶点。 Objective : To study the relation between uPA, uPAR, PAI-1 and invasion, metastasis of colon cancer and their relationship. Methods: Immunohistoehemistry SP - method was used to examine the expression of uPA, uPAR,PAI - 1 proteins in colon cancer (n = 156) and normal colon mueosa (n = 50). The data were processed by chi-square test and the correlation was analyzed by Spearman test. Results:uPA , uPAR PAI-1 were highly ex-pressed in colon cancer, with the decrease of differentiation, lymphatic metastasis, increase of clinical stage, the ex- pression was increased ( P 〈 0.05 ). In colon cancer uPA, uPAR, PAI-1 expression were corelated positively. Conclu-sion : uPA, uPAR, PAI-1 have very important promoting effect during colon cancer invasion and metastasis, they have coordinate action and promote each other during colon cancer invasion and metastasis. They all can be regarded as in-dexes for colon cancer diagnosis and prognosis evaluation and mav become new target of colon cancer gene therepy.
作者 乔雷 陈春生
出处 《现代肿瘤医学》 CAS 2012年第9期1876-1879,共4页 Journal of Modern Oncology
基金 辽宁省教育厅课题(编号:L2010609)
关键词 结肠癌 UPA UPAR PAI-1 colon cancer urokinase-type plasminogen activator urokinase- type plasminogen activator receptor plasminogen activator inhibitor - 1
  • 相关文献

参考文献10

  • 1Hildenbrand R, Allgayer H, Marx A, et al. Modulators of the uroki- nase- type plasminogen activation system for cancer [ J ]. Expert Opin Investig Drugs,2010,19(5) :641 -652. 被引量:1
  • 2Shin SM, Cho KS, Choi MS, et al. Urokinase - type plasminogen ac- tivator induces BV - 2 microglial cell migration through activation of matrix metalloproteinase - 9 [ J ]. Neurochem Res,2010,35 (7) : 976 - 985. 被引量:1
  • 3Tobar N, Villar V, Santibanez JF. ROS - NFkappaB mediates TGF - bet al - induced expression of urokinase - type plasminogen acti- vator, matrix metalloproteinase - 9 and cell invasion [ J ]. Mol Cell B iochem ,2010,340 ( 1 - 2 ) : 195 - 200. 被引量:1
  • 4王鑫,史晨辉,赵瑾,董金波,刘维钢,李宽新,王永明,李洪安.骨关节炎滑膜组织中uPA、uPAR、PAI-1 mRNA及蛋白的表达及其临床意义[J].临床骨科杂志,2009,12(2):217-221. 被引量:7
  • 5Halamkova J, Kiss I, Pavlovsky Z, et al. Clinical significance of the plasminogen activator system in relation to grade of tumor and treat- ment response in colorectal carcinoma patients [J]. Neoplasma, 2011,58(5) :377 -385. 被引量:1
  • 6Kotzsch M, Magdolen V, Greither T, et al. Combined mRNA expres- sion levels of members of the urokinase plasminogen activator (uPA) system correlate with disease - associated survival of soft - tissue sarcoma patients [ J ]. BMC Cancer,2011,11 ( 1 ) :273. 被引量:1
  • 7Kogianni G, Walker MM, Waxman J, et al. Endo180 expression with cofunctional partners MT1 - MMP and uPAR - uPA is correlated with prostate cancer progression [J].Eur J Cancer,2009,45 (4) : 685 - 693. 被引量:1
  • 8郑起,闫钧,潘烨,汪昱,冯昌宁.uPA、uPAR与胃癌分期和预后[J].肿瘤,2004,24(6):584-586. 被引量:2
  • 9Kimura H, Li X, Torii K, et al. Glucocorticoid enhances hypoxia - and/or transforming growth factor - 13 - induced plasminogen acti- vator inhibitor - 1 production in human proximal renal tubular cells [J]. Clin Exp Nephrol,2011,15( 1 ) :34 -40. 被引量:1
  • 10凌丹,李力,黎丹戎,张玮.卵巢恶性肿瘤组织中uPA及其PAI-1表达的临床意义[J].广西医科大学学报,2008,25(5):657-660. 被引量:3

二级参考文献19

  • 1李茂强,史晨辉,李宽新,胡文浩,王永明,刘维钢,董金波,李洪安.骨关节炎滑膜uPA,uPAR,tPA表达及意义[J].中国矫形外科杂志,2004,12(21):1686-1688. 被引量:16
  • 2何斌,史晨辉,王永明,孙建华,石辉.关节内注射尿激酶型纤溶酶原激活物对关节软骨的实验研究[J].石河子大学学报(自然科学版),2006,24(1):58-62. 被引量:2
  • 3蔡喆,李艳芳,刘富元,冯艳玲,侯景辉,赵美卿.上皮性卵巢癌组织中uPA和PAI-1的表达及意义[J].癌症,2007,26(3):312-317. 被引量:6
  • 4Altman R D. Criteria for classification of clinical osteoarthritis [ J ]. J Rheumatol , 1991,18 (2) : 102 - 121. 被引量:1
  • 5Szekaneca Z,Haines G K, Koch A E. Differential expressition of the urokinase receptor(CD87) in arthritic and normal synovial tissues[ J]. J Clin Pathol,1997,50(4) :314-319. 被引量:1
  • 6Ogilive-Harris D J, Jackson R W . The arthroscopic treatment Of chondromalacia patella[ J ]. J Bone Joint Surg Br, 1984,66 ( 5 ) : 660 - 665. 被引量:1
  • 7Shimada J , Suzuki Y, Kim S J, et al. Transactivation via RAR/ RXR2Sp1 interaction:characterization of binding between Sp1 and GC box motif[J]. Mol End, 2001, 15(10): 1677-1692. 被引量:1
  • 8Schwab W, Schulze T G, Mobasheri A, et al. 1 nterleukin-lbeta in duced expression of the urokinase-type plasnlinogen activator receptor and its co-localization with MMPs in humanarticular chondrocytcs[ J]. Histol Histopathol,2004,19 ( 1 ) : 105 - 112. 被引量:1
  • 9Jin T, Tarkowski A, Carmeliet P, et al. Umkinase, a constitutive component of the inflamed synovial fluid, induces arthritis[ J ]. Arthritis Res Ther,2003,5( 1 ) :R9 - R17. 被引量:1
  • 10Shakibaei M, Schulze-Tanzil G, et al. Expression of the VEGF receptor-3 in osteoarthritic chondroc ytes:stimulation by interleukin- 1 beta and association with beta 1-integrius [ J ]. Histochem Cell Biol, 2003,120 (3) :235 - 241. 被引量:1

共引文献9

同被引文献43

  • 1关海霞,单忠艳,米小轶,王恩华,滕卫平.普遍食盐碘化前后甲状腺癌发病变化的11年病理资料分析[J].中国医科大学学报,2006,35(3):284-285. 被引量:106
  • 2王小宁,霍介格.中医治疗大肠癌的思路与方法探讨[J].中国中医基础医学杂志,2007,13(9):681-682. 被引量:46
  • 3Borstnar S, Sadikov A, Mozina B,et al. High levels of uPA and PA1-1predict a good response to anthracyclines [ J ]. Breast Cancer ResTreat,2010,121 (3) :615~624. 被引量:1
  • 4Ek ET,Dass CR,Choong PF. PEDF:a potential molecular therapeutictarget with multiple anti-cancer activities [ J ]. Trends Mol Med ,2006 ,12(10) :497-502. 被引量:1
  • 5Dawson DW , Volpert OV, Gillis P, et al. Pigment epithelium-derivedfactor: a potent inhibitor of angiogenesis[J]. Science, 1999 , 285(5425 ) :245-248. 被引量:1
  • 6Ek ET,Dass CR,Contreras KG,et al. Pigment epilhelium-derived fac-tor o\rerexpression inhibits orthotopic osteosarcoma growth,angiogenti-sis and metastasis[ J]. Cancer Gene Ther,2007 ,14(7) :616-626. 被引量:1
  • 7Reis EM,Ojopi E P,Alberto FL,et al.Large-scale transcrip-tome analyses reveal new genetic marker candidates of head neck, and thyroid cancer.Cancer Res,2005,65:1693. 被引量:1
  • 8Duffy MJ, Maguim TM ,McDermott EW ,et al.Urokinase plas- minogen activator: A prognosticmaker in multiple types of cancer.J Surg Oncol, 1999,71 (2) : 130. 被引量:1
  • 9Behrendt N, Plouy M, Patthy L, et al. The ligand binding domain of the cell surface receptor for urokinase-type plas- minogen activator. Biol Chem, 1991.266(12):7842. 被引量:1
  • 10Botkjaer KA,Deryugina EI,Dupont DM,et al.Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism[J].Molecular Cancer Research,2012,10(12):1532-1543. 被引量:1

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部